Stocks and Investing Stocks and Investing
Fri, February 3, 2023
[ 12:00 AM ] - WOPRAI
David Williams Maintained (CRUS) at Strong Buy with Increased Target to $110 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Matthew Ramsay Maintained (CRUS) at Buy with Increased Target to $110 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Christopher Rolland Maintained (CRUS) at Buy with Increased Target to $110 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Ronald Kamdem Maintained (BXP) at Hold with Increased Target to $68 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Doug Creutz Maintained (SONY) at Buy with Increased Target to $118 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Christopher Kuhn Maintained (SNDR) at Strong Buy with Increased Target to $34 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jason Seidl Maintained (SNDR) at Buy with Increased Target to $34 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Christian Wetherbee Maintained (SNDR) at Hold with Increased Target to $31 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Ariel Rosa Maintained (SNDR) at Buy with Increased Target to $35 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Bert Subin Maintained (SNDR) at Strong Buy and Held Target at $35 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Ken Herbert Downgraded (SPR) to Hold and Decreased Target to $36 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
John Vinh Maintained (SYNA) at Buy with Increased Target to $160 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Martin Yang Downgraded (SYNA) to Hold on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Ambrish Srivastava Maintained (SYNA) at Hold with Increased Target to $135 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Krish Sankar Maintained (SYNA) at Buy with Increased Target to $150 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Anthony Stoss Maintained (SYNA) at Strong Buy with Increased Target to $150 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Christopher Rolland Maintained (SYNA) at Buy with Increased Target to $145 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Nathan Martin Reiterated (SXC) at Strong Buy and Held Target at $10 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Michael Legg Maintained (SXI) at Strong Buy and Held Target at $150 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
David Macgregor Downgraded (SWK) to Hold on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Joshua Pokrzywinski Maintained (SWK) at Hold with Increased Target to $97 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Eric Lau Upgraded (SWK) to Hold and Increased Target to $106 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Vivek Juneja Maintained (TFC) at Hold and Held Target at $50 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Rob Owens Maintained (TEAM) at Hold with Increased Target to $160 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Keith Weiss Maintained (TEAM) at Buy with Decreased Target to $185 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
David Hynes Maintained (TEAM) at Strong Buy with Increased Target to $175 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Paul Knight Maintained (TECH) at Buy with Decreased Target to $115 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Puneet Souda Maintained (TECH) at Buy with Decreased Target to $110 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Robert Wasserman Maintained (TECH) at Strong Buy and Held Target at $120 on, Feb 3rd, 2023
[ 12:00 AM ] - WOPRAI
Christopher Raymond Initiated (AGIO) at Buy and Held Target at $41 on, Feb 3rd, 2023

Christopher Raymond Initiated (AGIO) at Buy and Held Target at $41 on, Feb 3rd, 2023


Published on 2024-10-28 01:19:49 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Initiated "Agios Pharmaceuticals, Inc." (AGIO) at Buy and Held Target at $41 on, Feb 3rd, 2023.

Christopher has made no other calls on AGIO in the last 4 months.



There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, all agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Tessa Romero of "JP Morgan" Maintained at Hold with Decreased Target to $33 on, Thursday, December 1st, 2022
  • Salveen Richter of "Goldman Sachs" Upgraded from Strong Sell to Hold and Increased Target to $32 on, Thursday, November 17th, 2022
Contributing Sources